Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

0R0T

Amgen (0R0T)

Amgen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0R0T
DateTimeSourceHeadlineSymbolCompany
09/18/20192:28AMAlliance NewsAlliance NewsAmgen Progresses On AMG 510 Development For Treatment Of CancersLSE:0R0TAmgen Inc
09/13/20199:23AMAlliance NewsAlliance NewsAmgen Pleased With Potential Of Proposed Blood Cancer TreatmentLSE:0R0TAmgen Inc
09/09/20191:54AMAlliance NewsAlliance NewsAmgen Receives Good Results In Trial Of Proposed Lung Cancer DrugLSE:0R0TAmgen Inc
08/29/20196:53AMAlliance NewsAlliance NewsUS Court Invalidates Amgen Patent, Rules In Favour Of SanofiLSE:0R0TAmgen Inc
08/27/20192:22AMAlliance NewsAlliance NewsMoody's Says Amgen's Otezla Buy Credit Negative; Ratings UnchangedLSE:0R0TAmgen Inc
08/26/20196:49AMAlliance NewsAlliance NewsAmgen To Buy Otezla For USD13 Billion To Boost Inflammation PortfolioLSE:0R0TAmgen Inc
08/22/201912:26PMAlliance NewsAlliance NewsAmgen Reports Positive Results From Comparative Study Of ABP 798LSE:0R0TAmgen Inc
08/12/20191:32AMAlliance NewsAlliance NewsNovartis To Challenge Court Move To Prevent Erelzi Biosimilar LaunchLSE:0R0TAmgen Inc
07/19/20194:14AMAlliance NewsAlliance NewsTwo Amgen Biosimilar Cancer Treatments Now Available In USLSE:0R0TAmgen Inc
07/12/20191:57AMAlliance NewsAlliance NewsNovartis, Amgen Discontinue Clinical Study For Alzheimer's PreventionLSE:0R0TAmgen Inc
 Showing the most relevant articles for your search:LSE:0R0T